Cheney Free Press -

By EARL D. FOWLKES Jr.
Contributor 

To save lives, clinical trials need diversity

Commentary

 

Last updated 2/18/2021 at 11:39am



I’ve spent my career fighting for vulnerable patients, especially people of color. So I was ecstatic to hear about a new initiative from dozens of biotech companies.

These firms pledged to enroll more people of color in “clinical trials” — years-long tests that show whether experimental drugs are safe and effective. Boosting diversity will tangibly improve the health of minority Americans.

White Americans are drastically overrepresented in clinical trials. Non-Hispanic whites account for 60% of the U.S. population, but roughly 86% of clinical trial participants. By contrast, Black A...



For access to this article please sign in or subscribe.

 

Reader Comments(0)

 
 

Our Family of Publications Includes:

Cheney Free Press
Ritzville Adams County Journal
Whitman County Gazette
Odessa Record
Franklin Connection
Davenport Times
Spokane Valley News Herald
Colfax Daily Bulletin

Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2022